# EDGAR Filing Document

**Accession Number:** 0000055772
**File Stem:** 0000055772-23-000004
**Filing Date:** 2023-2
**Character Count:** 40216
**Document Hash:** 1eeb82b83cc65184790eb8c2b54a9ed7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000055772-23-000004.hdr.sgml**: 20230202

**ACCESSION NUMBER**: 0000055772-23-000004

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 32

**CONFORMED PERIOD OF REPORT**: 20230202

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230202

**DATE AS OF CHANGE**: 20230202

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KIMBALL INTERNATIONAL INC
- **CENTRAL INDEX KEY:** 0000055772
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOUSEHOLD FURNITURE [2510]
- **IRS NUMBER:** 350514506
- **STATE OF INCORPORATION:** IN
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-03279
- **FILM NUMBER:** 23580971

**BUSINESS ADDRESS:**
- **STREET 1:** 1600 ROYAL ST
- **CITY:** JASPER
- **STATE:** IN
- **ZIP:** 47546-2256
- **BUSINESS PHONE:** 8124821600

**MAIL ADDRESS:**
- **STREET 1:** 1600 ROYAL STREET
- **CITY:** JASPER
- **STATE:** IN
- **ZIP:** 47546-2256

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JASPER CORP
- **DATE OF NAME CHANGE:** 19740826

?xml version="1.0" ? kbal-20230202

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported) February 2, 2023

![kbal-20230202_g1.jpg](kbal-20230202_g1.jpg)

**KIMBALL INTERNATIONAL, INC.**

**________________________________________________________________________________________________________**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| Indiana | 0-3279 | 35-0514506 |
| (State or other jurisdiction of | (Commission File | (IRS Employer Identification No.) |
| incorporation) | Number) | |

---

---

| | |
|:---|:---|
| 1600 Royal Street, Jasper, Indiana | 47546-2256 |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code <u>(812) 482-1600</u>

Not Applicable <br> (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<u>Title of each Class</u>** | **<u>Trading Symbol(s)</u>** | **<u>Name of each exchange on which registered</u>** |
| Class B Common Stock, par value $0.05 per share | KBAL | The NASDAQ Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

------

**Item 2.02 Results of Operations and Financial Condition**

On February 2, 2023, Kimball International, Inc. (the "Company") issued an earnings release for the quarter ended December 31, 2022. The earnings release is attached as Exhibit 99.1.

**Item 7.01 Regulation FD Disclosure**

Attached hereto as Exhibit 99.2 is an investor presentation that supplements the information to be discussed on the Kimball International, Inc. earnings call to be held on February 2, 2023 at 5:00 p.m. Eastern Time. The presentation attached as Exhibit 99.2 is incorporated into this Item 7.01 by reference.

**Item 9.01 Financial Statements and Exhibits**

**(d) Exhibits**

---

| | |
|:---|:---|
| Exhibit |  |
| Number | Description |
| 99.1 | <u>[Q2 FY23 Earnings Press Release furnished on February 2, 2023](aex991pressrelease12312022.htm)</u> |
| 99.2 | <u>[Q](q2fy23kbalearningspresen.htm)[2](q2fy23kbalearningspresen.htm)[FY23 Quarterly Earnings and Strategic Update](q2fy23kbalearningspresen.htm)</u> |
| 104 | Cover Page interactive data file (embedded within the Inline XBRL document) |

---

The information in this Current Report on Form 8-K set forth in Item 2.02, Item 7.01, and Exhibits 99.1 and 99.2, is being furnished in accordance with the provisions of General Instruction B.2 of Form 8-K and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information contained in this Current Report on Form 8-K, including Exhibits 99.1 and 99.2, that is being furnished under Item 2.02 and Item 7.01 shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such filing.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| | KIMBALL INTERNATIONAL, INC. |
| By: | /s/ Timothy J. Wolfe |
|  | TIMOTHY J. WOLFE<br>Chief Financial Officer |

---

Date: February 2, 2023

## Exhibit 99.1

**Exhibit 99.1**

**KIMBALL INTERNATIONAL, INC. REPORTS SECOND QUARTER 2023 RESULTS**

**--Strong Growth in Sales and Operating Profits--**

**--Leadership in Ancillary Products and Secondary Geographies Continues to Drive Industry-leading Performance--**

**--Maintains Fiscal 2023 Guidance for Adjusted EBITDA Growth of 47% Despite Industry Headwinds--**

JASPER, IN (February 2, 2023) - Kimball International, Inc. (NASDAQ: KBAL) today announced results for the second quarter ended December 31, 2022.

**Selected Financial Highlights:** 

Second Quarter FY 2023

• Net sales of $183 million, increased 21% year-over-year

• Gross margin expanded 550 basis points to 36.2%

• Net loss of $36.1 million inclusive of a non-cash charge; Adjusted net income of $3.0 million

• Diluted EPS of $(0.99); Adjusted diluted EPS was $0.08

• Adjusted EBITDA of $16.0 million, up $12.0 million year-over-year

• Backlog of $144.8 million

**Management Commentary**

CEO Kristie Juster commented, **"**This marked our fourth consecutive quarter of substantial year-on-year growth in Adjusted EBITDA driven by sales gains and production efficiencies, representing the effective execution of our strategic choices. Second quarter sales growth of 21% included significant contributions from all our end markets, and especially from our Hospitality end market, where our leading market share position is enabling us to capture growth opportunities from that industry's post-Covid recovery.

"While upstream activity remains strong, we experienced a decline in orders rates in Workplace and Health during November and early December due to delayed decisions from clients in the face of recessionary concerns and after cycling significant year-over-year growth comps. However, our order rates improved through the month of January, giving us confidence the softening demand was temporary.

"Our optimized go-to-market strategy, which includes a portfolio of high appeal affordable products and greater focus on our direct and day-to-day businesses, is enabling us to adapt to these changing market conditions and successfully navigate the evolving hybrid workplace. We expect these initiatives, together with our cost-out and operational excellence programs, to provide Kimball International with resiliency in today's business environment."

**Overview**

**Second Quarter Fiscal 2023 Results**

Consolidated net sales increased 21% to $183 million from the year ago quarter, driven by growth in all three of the Company's end markets. Gross margin expanded 550 basis points year-over-year to 36.2%, due to continued price benefits amid moderating inflation and the easing of supply chain disruptions as well as benefits from LIFO accounting impacts. Selling and administrative expenses (S&A) declined as a percentage of net sales to 31.1%, 330 basis points below the 34.4% reported in last year's second quarter. Adjusted S&A was $54.7 million, or 29.9% of net sales, compared to $48.5 million, or 32.0% of net sales, in last year's second quarter. Net loss was $36.1 million, or $(0.99) per diluted share, inclusive of a $36.7 million after-tax non-cash goodwill impairment charge associated with the Poppin acquisition. Adjusted net income was $3.0 million, or $0.08 per diluted share, compared to adjusted net loss of $(5.7) million, or $(0.16) per diluted share in the second quarter of fiscal 2022. Adjusted EBITDA was $16.0 million compared to $4.0 million in the year ago quarter. Adjusted EBITDA margin was 8.8%, up from 2.7% in the year ago quarter.

Capital expenditures in the second quarter of fiscal year 2023 amounted to $6.1 million. Kimball International returned $5.2 million to shareholders in the form of dividends and share repurchases in the second quarter of fiscal year 2023.

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Net Sales by End Market** | **Net Sales by End Market** | **Net Sales by End Market** | **Net Sales by End Market** | | | |
| | **Three Months Ended** | **Three Months Ended** | | **Six Months Ended** | **Six Months Ended** | |
| (Unaudited) | **December 31,** | **December 31,** |  | **December 31,** | **December 31,** |  |
| (Amounts in Millions) | **2022** | **2021** | **% Change** | **2022** | **2021** | **% Change** |
| Workplace \* | $124.3 | $107.9 | 15% | $256.3 | $216.5 | 18% |
| Health | 31.0 | 26.6 | 17% | 57.1 | 49.6 | 15% |
| Hospitality | 27.7 | 16.9 | 64% | 47.4 | 41.9 | 13% |
| Total Net Sales | $183.0 | $151.4 | 21% | $360.8 | $308.0 | 17% |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Orders Received by End Market** | **Orders Received by End Market** | **Orders Received by End Market** | **Orders Received by End Market** | | | |
| | **Three Months Ended** | **Three Months Ended** | | **Six Months Ended** | **Six Months Ended** | |
| (Unaudited) | **December 31,** | **December 31,** |  | **December 31,** | **December 31,** |  |
| (Amounts in Millions) | **2022** | **2021** | **% Change** | **2022** | **2021** | **% Change** |
| Workplace \* | $109.4 | $132.1 | (17%) | $235.7 | $256.8 | (8%) |
| Health | 21.2 | 30.8 | (31%) | 50.9 | 59.7 | (15%) |
| Hospitality | 21.4 | 17.9 | 20% | 53.1 | 50.9 | 4% |
| Total Orders | $152.0 | $180.8 | (16%) | $339.7 | $367.4 | (8%) |

---

\* Workplace end market includes education, government, commercial, and financial vertical markets and eBusiness

**Summary and Outlook**

"This was another quarter of strong performance for Kimball International, which has put us on track to achieve our fiscal 2023 guidance for EBITDA growth of 47% at the midpoint. While we have adapted our revenue guidance to reflect heightened recessionary risk, we are confident in our ability to continue to grow profitability. As we move into the second half of fiscal 2023, we will continue to leverage our leadership in providing high-demand ancillary products to high growth domestic markets, reignite our Hospitality business and all while driving sustained gross margin improvement and diligence in investments for our future," Ms. Juster concluded.

---

| | | | |
|:---|:---|:---|:---|
| **FY 2023 Guidance Ranges** | **FY 2023 Guidance Ranges** | **FY 2023 Guidance Ranges** | **FY 2023 Guidance Ranges** |
|  | Low | High | YoY Growth |
| Revenue | $720 million | $740 million | 10% at midpoint |
| Adjusted EBITDA | $48 million | $52 million | 47% at midpoint |

---

The Company expects a sequential decline in Q3 revenue and gross margin with a recovery in Q4 as it enters the annual education buying season in the spring.

**Non-GAAP Financial Measures**

This press release contains non-GAAP financial measures. A non-GAAP financial measure is a numerical measure of a company's financial performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with Generally Accepted Accounting Principles ("GAAP") in the United States in the statements of operations, statements of comprehensive income, balance sheets, statements of cash flows, or statement of shareholders' equity of the Company. The non-GAAP financial measures used within this release include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• adjusted selling and administrative expense, defined as selling and administrative expense excluding market valuation adjustments related to our SERP liability, acquisition-related amortization adjustments, and COVID vaccine incentive costs;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• adjusted selling and administrative expense percentage, defined as adjusted selling and administrative expense as a percentage of net sales;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• adjusted operating income (loss), defined as operating income (loss) excluding restructuring expenses, goodwill impairment, market valuation adjustments related to our SERP liability, acquisition-related amortization and inventory valuation adjustments, contingent earn-out gain or loss, and COVID vaccine incentive costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• adjusted operating income (loss) percentage, defined as adjusted operating income as a percentage of net sales;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• adjusted net income (loss), defined as net income (loss) excluding restructuring expenses, goodwill impairment, acquisition-related amortization and inventory valuation adjustments, contingent earn-out gain or loss, and COVID vaccine incentive costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• adjusted diluted earnings (loss) per share, defined as diluted earnings (loss) per share excluding restructuring expenses, goodwill impairment, acquisition-related amortization and inventory valuation adjustments, contingent earn-out gain or loss, and COVID vaccine incentive costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• adjusted EBITDA, defined as earnings before interest, statutory income tax impacts for taxable after-tax measures, depreciation, and amortization and excluding restructuring expenses, goodwill impairment, acquisition-related inventory valuation adjustments, contingent earn-out gain or loss, and COVID vaccine incentive costs; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• adjusted EBITDA percentage, defined as adjusted EBITDA as a percentage of net sales.

Reconciliations of the reported GAAP numbers to these non-GAAP financial measures are included in the tables below. Management believes that adjusted EBITDA and other metrics excluding restructuring expense, goodwill impairment, market value adjustments related to the SERP liability, acquisition-related adjustments, and the COVID vaccine incentive are useful measurements to assist investors in comparing our performance over various reporting periods on a consistent basis by removing from operating results the impact of items that do not reflect our core operating performance.

The orders received metric is a key performance indicator used to evaluate general sales trends and develop future operating plans. Orders received represent firm orders placed by our customers during the current quarter which are expected to be recognized as revenue during current or future quarters. The orders received metric is not intended to be presented as an alternative measure of revenue recognized in accordance with GAAP.

**Forward-Looking Statements**

This document may contain certain forward-looking statements about the Company, such as discussions of the Company's pricing trends, liquidity, new business results, expansion plans, anticipated expenses and planned schedules. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. These statements generally can be identified by the use of words or phrases, including, but not limited to, "intend," "anticipate," "believe," "estimate," "project," "target," "plan," "expect," "setting up," "beginning to," "will," "should," "would," "resume" or similar statements. We caution that forward-looking statements are subject to known and unknown risks and uncertainties that may cause the Company's actual future results and performance to differ materially from expected results including, but not limited to, the risk that any projections or guidance by the Company, including revenues, margins, earnings, or any other financial results are not realized; a shortage of manufacturing labor and related cost; disruptions in our supply chain and freight channels including impacts on cost and availability; adverse changes in global economic conditions; successful execution of the second phase of the Company's restructuring plan; significant reduction in customer order patterns; loss of key suppliers; relationships with strategic customers and product distributors; changes in the regulatory environment; global health concerns (including the impact of the COVID-19 pandemic); or similar unforeseen events. Additional cautionary statements regarding other risk factors that could have an effect on the future performance of the Company are contained in filings made from time to time with the Securities and Exchange Commission, including but not limited to, our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

------

---

| | |
|:---|:---|
| **Conference Call / Webcast** | **Conference Call / Webcast** |
| Date: | February 2, 2023 |
| Time: | 5:00 PM Eastern Time |
| US Toll free Dial-In #: | 1-833-535-2198 |
| International Dial-In #: | 1-412-317-0667 |

---

A webcast of the live conference call may be accessed by visiting Kimball International's Investor Relations website at www.ir.kimballinternational.com.

For those unable to participate in the live webcast, the call will be archived at www.ir.kimballinternational.com within two hours of the conclusion of the live call.

**About Kimball International, Inc.**

Kimball International is a leading omnichannel commercial furnishings company with deep expertise in the Workplace, Health and Hospitality markets. We combine our bold entrepreneurial spirit, a history of craftsmanship and today's design-driven thinking alongside a commitment to our culture of caring and lasting connections with our customers, shareholders, employees and communities.

For over 70 years, our brands have seized opportunities to customize solutions into personalized experiences, turning ordinary spaces into meaningful places. Our family of brands includes Kimball, National, Etc., Interwoven, Kimball Hospitality, D'style and Poppin.

Kimball International is based in Jasper, Indiana.

www.kimballinternational.com

------

Financial highlights for the second quarter ended December 31, 2022 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Condensed Consolidated Statements of Operations** | | | | |
| (Unaudited) | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| (Amounts in Thousands, except per share data) | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** |
| Net Sales | $182947 | 100.0% | $151403 | 100.0% |
| Cost of Sales | 116810 | 63.8% | 104959 | 69.3% |
| Gross Profit | 66137 | 36.2% | 46444 | 30.7% |
| Selling and Administrative Expenses | 56795 | 31.1% | 51921 | 34.4% |
| Contingent Earn-Out (Gain) Loss | 0 | 0.0% | (22510) | (14.9%) |
| Restructuring Expense | 1679 | 0.9% | 1010 | 0.7% |
| Goodwill Impairment | 36684 | 20.1% | 34118 | 22.5% |
| Operating Income (Loss) | (29021) | (15.9%) | (18095) | (12.0%) |
| Other Income, net | 86 | 0.1% | 477 | 0.4% |
| Income (Loss) Before Taxes on Income | (28935) | (15.8%) | (17618) | (11.6%) |
| Provision for Income Taxes | 7128 | 3.9% | 3696 | 2.5% |
| Net Income (Loss) | $(36063) | (19.7%) | $(21314) | (14.1%) |
| Earnings (Loss) Per Share of Common Stock: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $(0.99) |  | $(0.58) |  |
| &nbsp;&nbsp;&nbsp;Diluted | $(0.99) |  | $(0.58) |  |
| Average Number of Total Shares Outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 36539 |  | 36749 |  |
| &nbsp;&nbsp;&nbsp;Diluted | 36539 |  | 36749 |  |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| (Unaudited) | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| (Amounts in Thousands, except per share data) | **December 31, 2022** | **December 31, 2022** | **December 31, 2021** | **December 31, 2021** |
| Net Sales | $360758 | 100.0% | $308013 | 100.0% |
| Cost of Sales | 235007 | 65.1% | 212472 | 69.0% |
| Gross Profit | 125751 | 34.9% | 95541 | 31.0% |
| Selling and Administrative Expenses | 110202 | 30.6% | 102080 | 33.1% |
| Contingent Earn-Out (Gain) Loss | (3160) | (0.9%) | (17900) | (5.8%) |
| Restructuring Expense | 2049 | 0.6% | 2465 | 0.8% |
| Goodwill Impairment | 36684 | 10.2% | 34118 | 11.1% |
| Operating Income (Loss) | (20024) | (5.6%) | (25222) | (8.2%) |
| Other Income (Expense), net | (1008) | (0.2%) | 43 | 0.0% |
| Income (Loss) Before Taxes on Income | (21032) | (5.8%) | (25179) | (8.2%) |
| Provision for Income Taxes | 8475 | 2.4% | 1184 | 0.4% |
| Net Income (Loss) | $(29507) | (8.2%) | $(26363) | (8.6%) |
| Earnings (Loss) Per Share of Common Stock: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $(0.81) |  | $(0.72) |  |
| &nbsp;&nbsp;&nbsp;Diluted | $(0.81) |  | $(0.72) |  |
| Average Number of Total Shares Outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 36647 |  | 36785 |  |
| &nbsp;&nbsp;&nbsp;Diluted | 36647 |  | 36785 |  |

---

------

---

| | | |
|:---|:---|:---|
| | (Unaudited) | |
| **Condensed Consolidated Balance Sheets** | **December 31,<br>2022** | **June 30,<br>2022** |
| (Amounts in Thousands) | **December 31,<br>2022** | **June 30,<br>2022** |
| **ASSETS** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $14067 | $10934 |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivables, net | 60073 | 79301 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 104812 | 97969 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 15531 | 30937 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and Equipment, net | 95609 | 96970 |
| &nbsp;&nbsp;&nbsp;&nbsp;Right of use operating lease assets | 13168 | 12839 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 11160 | 47844 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Intangible Assets, net | 52563 | 54767 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred Tax Assets | 16476 | 14472 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Assets | 14742 | 15245 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Assets | $398201 | $461278 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current maturities of long-term debt | 0 | 33 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 57249 | 70936 |
| &nbsp;&nbsp;&nbsp;&nbsp;Customer deposits | 32171 | 29706 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of operating lease liability | 5709 | 6096 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends payable | 3715 | 3623 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 36739 | 41088 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt, less current maturities | 60000 | 68046 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term operating lease liability | 12015 | 12150 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 13402 | 16064 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shareholders' Equity | 177201 | 213536 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities and Shareholders' Equity | $398201 | $461278 |

---

---

| | | |
|:---|:---|:---|
| **Condensed Consolidated Statements of Cash Flows** | **Six Months Ended** | **Six Months Ended** |
| (Unaudited) | **December 31,** | **December 31,** |
| (Amounts in Thousands) | **2022** | **2021** |
| Net Cash Flow provided by Operating Activities | $31533 | $12620 |
| Net Cash Flow used for Investing Activities | (11105) | (11313) |
| Net Cash Flow used for Financing Activities | (17871) | (9649) |
| Net Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash | 2557 | (8342) |
| Cash, Cash Equivalents, and Restricted Cash at Beginning of Period | 11996 | 25727 |
| Cash, Cash Equivalents, and Restricted Cash at End of Period | $14553 | $17385 |

---

------

---

| |
|:---|
| **Reconciliation of Non-GAAP Financial Measures** |
| (Unaudited) |
| (Amounts in Thousands, except per share data) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Adjusted Selling and Administrative Expense** | **Adjusted Selling and Administrative Expense** | **Adjusted Selling and Administrative Expense** | | |
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| Selling and Administrative Expense, as reported | $56795 | $51921 | $110202 | $102080 |
| Less: Pre-tax Expense Adjustment to SERP Liability | (619) | (680) | (160) | (587) |
| Less: Pre-tax Acquisition-related Amortization | (1502) | (1610) | (3004) | (3220) |
| Less: Pre-tax COVID Vaccine incentive | 0 | (1140) | 0 | (1140) |
| Adjusted Selling and Administrative Expense | $54674 | $48491 | $107038 | $97133 |
| Adjusted Selling and Administrative Expense % | 29.9% | 32.0% | 29.7% | 31.5% |
| **Adjusted Operating Income (Loss)** | **Adjusted Operating Income (Loss)** | **Adjusted Operating Income (Loss)** |  |  |
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| Operating Income (Loss), as reported | $(29021) | $(18095) | $(20024) | $(25222) |
| Add: Pre-tax Restructuring Expense | 1679 | 1010 | 2049 | 2465 |
| Add: Pre-tax Goodwill Impairment | 36684 | 34118 | 36684 | 34118 |
| Add: Pre-tax Expense Adjustment to SERP Liability | 619 | 680 | 160 | 587 |
| Add: Pre-tax Acquisition-related Amortization | 1502 | 1610 | 3004 | 3220 |
| Add: Pre-tax Acquisition-related Inventory Valuation Adjustment | 0 | 62 | 0 | 205 |
| Add: Pre-tax Contingent Earn-Out (Gain) Loss | 0 | (22510) | (3160) | (17900) |
| Add: Pre-tax COVID vaccine incentive | 0 | 2709 | 0 | 2709 |
| Adjusted Operating Income (Loss) | $11463 | $(416) | $18713 | $182 |
| Adjusted Operating Income (Loss)% | 6.3% | (0.3%) | 5.2% | 0.1% |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Adjusted Net Income (Loss)** | **Adjusted Net Income (Loss)** | **Adjusted Net Income (Loss)** | | |
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| Net Income (Loss), as reported | $(36063) | $(21314) | $(29507) | $(26363) |
| Pre-tax Restructuring Expense | 1679 | 1010 | 2049 | 2465 |
| Tax on Restructuring Expense | (431) | (259) | (527) | (634) |
| &nbsp;&nbsp;&nbsp;&nbsp;Add: After-tax Restructuring Expense | 1248 | 751 | 1522 | 1831 |
| Pre-tax Goodwill Impairment | 36684 | 34118 | 36684 | 34118 |
| Tax on Goodwill Impairment | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Add: After-tax Goodwill Impairment | 36684 | 34118 | 36684 | 34118 |
| Pre-tax Acquisition-related Amortization | 1502 | 1610 | 3004 | 3220 |
| Tax on Acquisition-related Amortization | (386) | (414) | (773) | (829) |
| &nbsp;&nbsp;&nbsp;&nbsp;Add: After-tax Acquisition-related Amortization | 1116 | 1196 | 2231 | 2391 |
| Pre-tax Acquisition-related Inventory Valuation Adjustment | 0 | 62 | 0 | 205 |
| Tax on Acquisition-related Inventory Valuation Adjustment | 0 | (16) | 0 | (53) |
| &nbsp;&nbsp;&nbsp;&nbsp;Add: After-tax Acquisition-related Inventory Adjustment | 0 | 46 | 0 | 152 |
| Pre-tax Contingent Earn-Out (Gain) Loss | 0 | (22510) | (3160) | (17900) |
| Tax on Contingent Earn-Out (Gain) Loss | 0 | 0 | 0 | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Add: After-tax Contingent Earn-Out (Gain) Loss | 0 | (22510) | (3160) | (17900) |
| Pre-tax COVID Vaccine Incentive | 0 | 2709 | 0 | 2709 |
| Tax on COVID Vaccine Incentive | 0 | (697) | 0 | (697) |
| &nbsp;&nbsp;&nbsp;&nbsp;Add: After-tax COVID Vaccine Incentive | 0 | 2012 | 0 | 2012 |
| Adjusted Net Income (Loss) | $2985 | $(5701) | $7770 | $(3759) |
| **Adjusted Diluted Earnings (Loss) Per Share** | **Adjusted Diluted Earnings (Loss) Per Share** | **Adjusted Diluted Earnings (Loss) Per Share** |  |  |
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| Diluted Earnings (Loss) Per Share, as reported | $(0.99) | $(0.58) | $(0.81) | $(0.72) |
| Add: After-tax Restructuring Expense | 0.04 | 0.02 | 0.05 | 0.05 |
| Add: After-tax Goodwill Impairment | 1.00 | 0.93 | 1.00 | 0.93 |
| Add: After-tax Acquisition-related Amortization | 0.03 | 0.03 | 0.06 | 0.07 |
| Add: After-tax Acquisition-related Inventory Valuation Adjustment | 0.00 | 0.00 | 0.00 | 0.01 |
| Add: After-tax Contingent Earn-Out (Gain) Loss | 0.00 | (0.61) | (0.09) | (0.49) |
| Add: After-tax COVID Vaccine Incentive | 0.00 | 0.05 | 0.00 | 0.05 |
| Adjusted Diluted Earnings (Loss) Per Share | $0.08 | $(0.16) | $0.21 | $(0.10) |

---

&nbsp;&nbsp;&nbsp;&nbsp;

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Adjusted EBITDA** | **Adjusted EBITDA** | **Adjusted EBITDA** | | |
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| Net Income (Loss) | $(36063) | $(21314) | $(29507) | $(26363) |
| Provision for Income Taxes | 7128 | 3696 | 8475 | 1184 |
| Income (Loss) Before Taxes on Income | (28935) | (17618) | (21032) | (25179) |
| Interest Expense | 696 | 275 | 1377 | 532 |
| Interest Income | (112) | (43) | (189) | (52) |
| Depreciation | 3806 | 3623 | 7440 | 7185 |
| Amortization | 2219 | 2415 | 4414 | 4854 |
| Pre-tax Restructuring Expense | 1679 | 1010 | 2049 | 2465 |
| Pre-tax Goodwill Impairment | 36684 | 34118 | 36684 | 34118 |
| Pre-tax Acquisition-related Inventory Valuation Adjustment | 0 | 62 | 0 | 205 |
| Pre-tax Contingent Earn-Out (Gain) Loss | 0 | (22510) | (3160) | (17900) |
| Pre-tax COVID Vaccine Incentive | 0 | 2709 | 0 | 2709 |
| Adjusted EBITDA | $16037 | $4041 | $27583 | $8937 |
| Adjusted EBITDA % | 8.8% | 2.7% | 7.6% | 2.9% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Supplementary Information** | | | | |
| **Components of Other Income (Expense), net** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| (Unaudited) | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
| (Amounts in Thousands) | **2022** | **2021** | **2022** | **2021** |
| Interest Income | $112 | $43 | $189 | $52 |
| Interest Expense | (696) | (275) | (1377) | (532) |
| Gain on Supplemental Employee Retirement Plan Investments | 619 | 680 | 160 | 587 |
| Other Non-Operating Income (Expense) | 51 | 29 | 20 | (64) |
| Other Income (Expense), net | $86 | $477 | $(1008) | $43 |

---

For additional information contact:

Chris Kuepper - chris.kuepper@kimballinternational.com

Lynn Morgen - lynn.morgen@advisiry.com

Eric Prouty - eric.prouty@advisiry.com

Kimball International

1600 Royal Street

Jasper, IN 47546-2256

Telephone 812.482.1600

## Exhibit 99.2

![](q2fy23kbalearningspresen001.jpg)

Q2 FY '23 Quarterly Earnings & Strategic Update February 2, 2023 Exhibit 99.2

------

![](q2fy23kbalearningspresen002.jpg)

Safe Harbor Statement This document may contain certain forward-looking statements about the Company, such as discussions of Company's pricing trends, liquidity, new business results, expansion plans, anticipated expenses and planned schedules. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. These statements generally can be identified by the use of words or phrases, including, but not limited to, "intend," "anticipate," "believe," "estimate," "project," "target," "plan," "expect," "setting up," "beginning to," "will," "should," "would," "resume" or similar statements. We caution that forward-looking statements are subject to known and unknown risks and uncertainties that may cause the Company's actual future results and performance to differ materially from expected results including, but not limited to, the risk that any projections or guidance by the Company, including revenues, margins, earnings, or any other financial results are not realized; a shortage of manufacturing labor and related cost; disruptions in our supply chain and freight channels including impacts on cost and availability; adverse changes in global economic conditions; successful execution of the second phase of the Company's restructuring plan; significant reduction in customer order patterns; loss of key suppliers; relationships with strategic customers and product distributors; changes in the regulatory environment; global health concerns; the potential for impairment of goodwill; or similar unforeseen events. Additional cautionary statements regarding other risk factors that could have an effect on the future performance of the Company are contained in filings made from time to time with the Securities and Exchange Commission, including but not limited to, our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. 2 \|

------

![](q2fy23kbalearningspresen003.jpg)

 21% increase in Q2 FY '23 sales driven by relevance of portfolio and focus on key markets  Fourth consecutive quarter of substantial year- over-year profitability gains  Confirming full-year FY '23 EBITDA guidance  New unified Perfect Harmony infrastructure delivers seamless experience across all our brands  Corporate Headquarters in Jasper advanced WELL certification to Platinum status Key Takeaways 3 \|

------

![](q2fy23kbalearningspresen004.jpg)

Expertise in Ancillary Products & Secondary Geographies1 Major SecondarySystems Ancillary 88% 79% ANCILLARY PRODUCTS SECONDARY GEOGRAPHIES The office is evolving into a place to foster collaboration and culture development as companies return to hybrid or fully in-person settings Ancillary products provide the flexibility and aesthetics that employers are looking for in this post-pandemic environment Secondary geographies are experiencing a faster return to office We have a strong, long-time presence, established relationships, and noticeable momentum in these key markets 4 \| 1 Based on trailing-twelve-months sales

------

![](q2fy23kbalearningspresen005.jpg)

 Workplace sales increased 15% in Q2 FY '23 year-over-year  Poppin pod category revenue up more than 75% in Q2 FY '23 year-over-year  PoppinPro over 15% of total Poppin sales for fourth quarter in a row  Health net sales increased 17% in Q2 FY '23 year-over-year  Key supplier to Health Trust, one of the largest group purchasing organizations in the U.S.  Hospitality sales increased 64% in Q2 FY '23 year-over-year, with orders increasing 20% year-over-year End Markets 5

------

![](q2fy23kbalearningspresen006.jpg)

Q2 FY '23 Financial Highlights1 36.2% GROSS MARGIN $54.7M ADJ. S&A EXPENSE2 $3.0M ADJ. NET INCOME2 $0.08 ADJ. EPS2 $183.0M REVENUE $16.0M ADJ. EBITDA2 1 Unaudited. 2 Non-GAAP Financial Measure. See Appendix for Non-GAAP reconciliations. $56.8M S&A EXPENSE $(36.1M) NET INCOME $(0.99) EPS 6 \|

------

![](q2fy23kbalearningspresen007.jpg)

7 New Multi-Branded Kimball Int'l Website Launching in February 2023

------

![](q2fy23kbalearningspresen008.jpg)

$27.7 $16.9 Q2 FY22 Q2 FY23 $183.0 $151.4 Q2 FY22 Q2 FY23 $31.0 $26.6 Q2 FY22 Q2 FY23 Quarterly Sales by Market1 Year-over-year Quarter Comparison Q2 '23 vs. Q2 '22 (in millions) 8 1 Unaudited. 2 Workplace end market includes commercial, educational, government and financial verticals and eBusiness Workplace2 $124.3 $107.9 Q2 FY22 Q2 FY23 +15% Hospitality +64% Health +17% Kimball International +21%

------

![](q2fy23kbalearningspresen009.jpg)

$21.4 $17.9 Q2 FY22 Q2 FY23 $144.8 $152.0 $196.9 $180.8 Q2 FY22 Q2 FY23 $21.2 $30.8 Q2 FY22 Q2 FY23 Backlog and Quarterly Orders by Market1 Year-over-year Quarter Comparison Q2 '23 vs. Q2 '22 (in millions) 9 1 Unaudited. 2 Workplace end market includes commercial, educational, government and financial verticals and eBusiness Workplace2 $109.4 $132.1 Q2 FY22 Q2 FY23 -17% Hospitality +20% Health -31% Kimball International -16% -26% O rd er s Ba ck lo g

------

![](q2fy23kbalearningspresen010.jpg)

Q2 FY '23 Liquidity and Capital Allocation $77.3M CASH, CASH EQUIVALENTS, PLUS THE UNUSED AMOUNT OF OUR CREDIT FACILITY 1 0 \| $6.1M CAPEX $5.2M TOTAL CAPITAL RETURNED TO SHAREHOLDERS $13.4M CASH FROM OPERATIONS

------

![](q2fy23kbalearningspresen011.jpg)

FY '23 Guidance $720M - $740M REVENUE $48M - $52M ADJUSTED EBITDA 1 1 Despite the current demand environment and considering our order trends through January, we are pleased to maintain our adjusted EBITDA guidance of $48-$52M. However, due to the uncertain macro-economic and demand environment, we are lowering our revenue guidance to $720-740 million. We expect a sequential decline in Q3 revenue and gross margin with a recovery in Q4 as we enters the annual education buying season in the spring.

------

![](q2fy23kbalearningspresen012.jpg)

 Solid first half of fiscal 2023, primed for another year of growth  Successfully delivering products and solutions to end markets and geographies of high growth, resiliency, and favorable return-to-office dynamics  Confident in ability to gain share and outperform the industry, while being mindful of challenging macroeconomic environment and heightened recessionary risks  Strong, well-aligned product portfolio with relevance to the emerging trends in today's marketplaces Looking Ahead Whittaker Lounge by Kimball, Frill Tables by David Edward, Idara Chair & Whimsy Ottoman by National, Xanthe Credenza by Etc. 1 2 \|

------

![](q2fy23kbalearningspresen013.jpg)

Environmental, Social and Governance (ESG) Roadmap Our Vision for Impact 5 Focus Areas Environmental, Social & Governance (ESG) Roadmap Kimball International is dedicated to building a more sustainable future and making a difference in our communities through five important focus areas. Environmental Management & Sustainable Products Investing In Our People with Talent Development Diversity, Equity, Inclusion & Belonging Product Quality & Safety Responsible Supply Chain Management 1 2 3 4 5 1 3 \|

------

![](q2fy23kbalearningspresen014.jpg)

Appendix

------

![](q2fy23kbalearningspresen015.jpg)

Non-GAAP Reconciliation (Unaudited) APPENDIX 1 5 \|

------

![](q2fy23kbalearningspresen016.jpg)

Non-GAAP Reconciliation (Unaudited) (cont.) APPENDIX 1 6 \|

------